Collectively, we identify IL3RA as a direct downstream target of EP300-ZNF384, suggesting CD123 is a potent biomarker for EP300-ZNF384-driven B-ALL. This evidence concerns the gene IL3RA and precursor B-cell acute lymphoblastic leukemia.